RJT
TDOC icon

Raymond James Trust’s Teladoc Health TDOC Stock Holding History

Raymond James Trust’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-22,808
Closed -$492K – 1278
2023
Q4 		$492K Sell
22,808
-1,000
-4% -$18.4K 0.01% 705
2023
Q3 		$443K Buy
23,808
+764
+3% +$17.8K 0.01% 698
2023
Q2 		$583K Buy
23,044
+1,525
+7% +$38.4K 0.02% 601
2023
Q1 		$557K Buy
21,519
+4,768
+28% +$128K 0.02% 589
2022
Q4 		$396K Buy
16,751
+3,329
+25% +$89.8K 0.01% 701
2022
Q3 		$340K Buy
13,422
+523
+4% +$18.3K 0.01% 735
2022
Q2 		$428K Buy
12,899
+1,448
+13% +$61.5K 0.02% 641
2022
Q1 		$826K Buy
11,451
+827
+8% +$59.6K 0.03% 466
2021
Q4 		$976K Sell
10,624
-656
-6% -$78.4K 0.03% 435
2021
Q3 		$1.43M Buy
11,280
+309
+3% +$45K 0.05% 310
2021
Q2 		$1.82M Sell
10,971
-34
-0.3% -$5.51K 0.06% 267
2021
Q1 		$2M Buy
11,005
+632
+6% +$147K 0.07% 241
2020
Q4 		$2.07M Sell
10,373
-293
-3% -$59.6K 0.08% 219
2020
Q3 		$2.34M Buy
10,666
+256
+2% +$54.2K 0.1% 176
2020
Q2 		$1.99M Buy
10,410
+844
+9% +$148K 0.1% 183
2020
Q1 		$1.48M Buy
9,566
+155
+2% +$18K 0.09% 202
2019
Q4 		$788K Buy
9,411
+25
+0.3% +$1.9K 0.04% 358
2019
Q3 		$635K Buy
9,386
+726
+8% +$47.8K 0.03% 394
2019
Q2 		$575K Hold
8,660
– – 0.03% 404
2019
Q1 		$482K Sell
8,660
-373
-4% -$22.8K 0.03% 434
2018
Q4 		$448K Buy
9,033
+1,089
+14% +$66.6K 0.03% 419
2018
Q3 		$686K Buy
7,944
+100
+1% +$7.13K 0.04% 353
2018
Q2 		$455K Sell
7,844
-143
-2% -$6.98K 0.03% 443
2018
Q1 		$322K Sell
7,987
-1,735
-18% -$65.5K 0.02% 504
2017
Q4 		$339K Sell
9,722
-221
-2% -$7.34K 0.02% 505
2017
Q3 		$330K Buy
9,943
+2,643
+36% +$86.7K 0.02% 504
2017
Q2 		$253K Buy
+7,300
New +$213K 0.02% 580

Other funds holding TDOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

Raymond James Trust's TDOC Position: Q1 2024 in Review

Raymond James Trust sold out of Teladoc Health (TDOC) in Q1 2024, closing a stake of 22,808 shares — an estimated $492K sold.

Raymond James Trust first reported a position in TDOC in Q2 2017 and held it in 27 quarters. The position peaked at $2.34M in Q3 2020. 426 funds tracked by Wall St. Rank hold TDOC as of Q1 2024.

  • Raymond James Trust reported no remaining Teladoc Health position as of Q1 2024 after selling out during the quarter.
  • Raymond James Trust sold 22,808 Teladoc Health shares in Q1 2024, an estimated $492K.
  • Raymond James Trust first reported a position in Teladoc Health in Q2 2017 and held it in 27 quarters.
  • Raymond James Trust's Teladoc Health position peaked at $2.34M in Q3 2020.
  • 426 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2024.

Based on Raymond James Trust's 13F filing for Q1 2024, filed 24 Apr 2024.